FDA Investigator Nimmy Mathews

Nimmy Mathews has conducted inspections on 32 sites in 4 countries as of 22 Jun 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
32
Last Inspection Date:
22 Jun 2021
Investigator Role:
FDA Investigator
Redica ID:
100009186
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Puerto Rico, Switzerland
FDA Investigators that have inspected at least one site in common with Nimmy Mathews:
Abby Lmozeke Baker, Addam S Reynolds, Adrian Rodriguez, Alan P Kurtzberg, Albert F Peacock, PhD, Alberto A Viciedo, Amanda J White, Anh M Lac, Ann Marie Montemurro, Anna R Kwilas, Annette Melendez, Anya Dlockett Evans, Arie R Dyk, Barbara D Wright, Blondell W Johnson, Bobbi J Miller, Bonnie L Menzel, Bradley Dworak, PhD, Brandon K Barbee, Burnell M Henry, Byungja E Marciante, Carmen Y Fisher, Casey L Hamblin, Cassandra L Abellard, Cathleen A Castellaw, Chad R Burger, Charles D Brown, Christopher D Rush, Christopher J Smith, Claire M Minden, Cody D Rickman, Connie L Hannon Rabel, Cynthia Jim, CSO, Dallas E Gilbreath Jr, Dana M Klimavicz, Darla J Christopher, David M Beltran, Dawn L Wydner, Deborah M Trout, Decarlos A Gomez, Deniza Karacic, Dennis R Hudson, Destry M Sillivan, Dorothy J Denes, Eddie J Rigsby, Eliezar Ramos, Elisa M Fleming, Elizabeth D Connell, Elmina E Akwo, Emily A Walters, Eric T Huebler, Erin D Mccaffery, Everard A Irish, Gene D Arcy, German Rivera, Haley H Seymour, Heba A Degheidy, Helen B Ricalde, Ingrid Y Johnson, J Elkins, Jacqueline Mdiaz Albertini, Jamie M Bumpas, Janet B Abt, Janet L Bowen, Jeffrey R Wooley, Jennifer O Dowdy, Jocelyn C Turner, Jodi M Gatica, John A Iwen, Jonathan A Womack, Jose A Moreno, Jose Acruz Gonzalez, Jose M Cayuela, Jose Martinez, Jr, Joyce A Rockwell, Juanelma H Palmer, Judy Ellen Ciaraldi, Julie D Bringger, Justine Tomasso, Karlton T Watson, Kathleen B Swat, Kathleen Chmura Shaffer, Kimberly L Schultz, L Grant, Laiza V Garcia, Latorie S Jones, Laura E Garcia, Lauren M Lilly, PhD, Laurimer Kuilan Torres, Lily Y Koo, Linda F Murphy, Linda Thai, Lisa M Puttonen, Lisa R Hilliar, Lisa R Jennings, Lisa R Whitt, Liza L Quiles, Loan T Tran, Lori G Cantin, Lorie S Hannappel, Lourdes Andujar, Lourdes R Genera, Lucas B Leake, Luis Soto Lopez, Lynnette I Riggio, Maira P Brading, Margaret M Annes, Margaret M Sands, Mark W Rivero, Martha S Baldwin, Massoud Motamed, Matthew R Maddox, Matthew W Klinker, Megan T Ziegler, Melissa T Roy, Mercy O Quagraine, Merelynn Rhoten, Michael C Kennedy, PhD, Michael Serrano, Michele L Forster, PhD, Michelle A Marsh, Michelle Paxon, Mihaly S Ligmond, Monique M Brooks, Monique Rac Lester, Nancy L Neiger, Nancy S Henley, Nancy T Waites, Nicholas A Violand, Nina Yang, Noreen Muñiz, Omotunde O Osunsanmi, Pablo Feliciano, Patrice S Hall, Paul M Chefor, Paula A Trost, Pauline N Logan, Peter R Lenahan, Philip M Steele, PhD, Prabhu P Raju, Prajakta A Varadkar, Qiao Y Bobo, Randa Melhem, PhD, Randy D Baxter, Randy L Clarida, Rhonda L Dash, Richard Jay Tucker, RS, Robert M Tillman, Ronda Rloyd Jones, Ruth A Williams, Sandy J Ziegler, Scott T Ballard, Sean M Cheney, Seri L Essary, Sha'tina R Alridge, Shanna N Purdy, Sharon K Thoma, PharmD, Shawn E Larson, Sherrie L Krolczyk, Sidney B Priesmeyer, Simone E Pitts, Stephen L Beekman, Susan M Jackson, Tamera H Hunt, Tamil Arasu, PhD, Tara A Gray, Toby Vern H Hill, Tracy J Washington, Trina K Vick, Tyanna N Hadley, Unnee Ranjan, William F Lagud, Jr, Yiping Jia, Yonggang Wang, PhD, Young M Yoon, Yvesna C Blaise, Zachary L Miller

Nimmy Mathews's Documents

Publish Date Document Type Title
May, 2019 FDA 483 Texoma Regional Blood Center - Form 483, 2019-05-03
July, 2021 FDA 483 Response Baxalta US Inc. - Form 483R, 2021-07-23
February, 2021 EIR CELGENE CORPORATION - EIR, 2021-03-10
March, 2019 FDA 483 Oklahoma Blood Institute Norman Center - Form 483, 2019-03-22
April, 2018 EIR United Laboratories Manufacturing, LLC - EIR, 2018-04-09
November, 2019 FDA 483 LifeShare Blood Center - Form 483, 2019-11-19
May, 2018 EIR Aurorium LLC - EIR, 2018-05-14
September, 2019 FDA 483 Fenwal International, Inc. - Form 483, 2019-09-26
May, 2018 FDA 483 Response Aurorium LLC - Form 483R, 2018-06-01
May, 2019 FDA 483 Texoma Regional Blood Center - Form 483, 2019-05-07
June, 2019 FDA 483 Response Oklahoma Blood Institute - Sylvan N Goldman Center - Form 483R, 2019-06-24
May, 2018 FDA 483 Aurorium LLC - Form 483, 2018-05-14
September, 2017 FDA 483 SCA Pharmaceuticals, Inc. - Form 483, 2017-09-29
July, 2019 FDA 483 Carter BloodCare - Baylor - Form 483, 2019-07-25
April, 2018 FDA 483 United Laboratories Manufacturing, LLC - Form 483, 2018-04-09
February, 2020 FDA 483 CSL Behring AG - Form 483, 2020-02-18
July, 2021 FDA 483 Baxalta US Inc. - Form 483, 2021-07-01
July, 2021 EIR Baxalta US Inc. - EIR, 2021-07-01
February, 2019 FDA 483 Midwest Transplant Network - Form 483, 2019-02-19
July, 2017 FDA 483 I.V. Specialty, Ltd - Form 483, 2017-07-28
February, 2021 FDA 483 Response CELGENE CORPORATION - Form 483R, 2021-03-11
January, 2020 FDA 483 Cleveland Cord Blood Center - Form 483, 2020-01-17
February, 2020 FDA 483 Millipore (U.K.) Ltd. - Form 483, 2020-02-27
September, 2017 EIR SCA Pharmaceuticals, Inc. - EIR, 2017-09-29
June, 2019 FDA 483 Oklahoma Blood Institute - Sylvan N Goldman Center - Form 483, 2019-06-07
April, 2018 FDA 483 Response United Laboratories Manufacturing, LLC - Form 483R, 2018-04-30
February, 2021 FDA 483 CELGENE CORPORATION - Form 483, 2021-02-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more